Affordable medication leaves biggest Dutch insurers cold
Aegon and Allianz have invested a total of no less than 11 billion euros in 19 pharmaceutical companies in 2019 without encouraging them to reduce high drug prices. These insurers also lack the commitment to prevent tax avoidance by pharmaceutical giants. This is the conclusion of a new study(opens in new window) by the Fair Insurance Guide(opens in new window) into investments by insurers in pharmaceuticals, conducted by SOMO.
Peter Ras, spokesperson for the Fair Insurance Guide:
“Affordable medication is of vital importance, especially for poor people in the Netherlands and in developing countries. Insurers have to increase their pressure on pharmaceutical companies to make affordable medicines and pay their fair share of taxes.”
Read the whole article in Dutch.
The Fair Insurance Guide is a collaboration between Amnesty International, FNV, Milieudefensie, Oxfam Novib, PAX and World Animal Protection. The nine insurers all participated in this investigation and were given the opportunity to respond to the investigation findings.
Partners
-
Eerlijke Verzekeringswijzer
Related news
-
-
-
Proposal European Parliament to make contracts between Europe and corona vaccine suppliers publicPosted in category:NewsPublished on:
